查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1575484

腸溶膠囊市場：按功能、聚合物、機制、通路、給藥途徑、治療領域 - 2025-2030 年全球預測

Enteric Capsule Market by Functionality, Polymer, Mechanism, Distribution Channel, Route of Administration, Therapeutic Area - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年腸溶膠囊市值為6.7453億美元，預計到2024年將達到7.1332億美元，複合年成長率為5.81%，到2030年將達到10.0163億美元。

腸溶膠囊市場包括旨在在腸道而不是胃中釋放活性藥物成分（API）的標靶藥物遞送產品。這些膠囊對於保護敏感 API 免受胃酸侵害、增強藥效並減少胃腸道副作用至關重要。廣泛應用於抗生素、酵素製劑、益生菌製劑等醫藥產品。最終用途包括藥品和食品，主要行業是醫院、診所和網路藥局。市場促進因素包括對標靶藥物輸送系統的需求不斷增加、人口老化需要改進藥物輸送方法以及胃腸道健康意識的提高。膠囊設計和材料的技術進步提供了多種成長機會，特別是在生物分解性和無毒塗層的開發方面。新的機會在於個人化醫療，腸溶膠囊可以根據特定患者的需求進行客製化，為精準藥物輸送鋪平道路。製造商面臨的挑戰是原料高成本且監管要求嚴格，這可能會阻礙市場成長。另一個限制是需要專門的基礎設施來製造這些膠囊。為了克服這些挑戰，公司可以投資研發，創新具有成本效益的製造程序，並探索用於膠囊製造的生物分解性材料。最有前景的創新領域包括開發多室膠囊，可容納不同的原料藥，並按順序釋放以實現複雜的治療方法。進一步探索奈米技術以提高腸溶膠囊在可變 pH 條件下的穩定性也可能提供競爭優勢。市場競爭溫和，主要參與者主要透過併購和策略聯盟來擴大市場佔有率並豐富產品陣容。腸溶膠囊市場的相關人員必須強調產品差異化和遵守嚴格的衛生法規，以便在不斷變化的消費者需求中保持成長。

主要市場統計
基準年[2023] 67453萬美元
預測年份 [2024] 71332萬美元
預測年份 [2030] 1,001,630,000 美元
複合年成長率（%） 5.81%

市場動態：快速發展的腸溶膠囊市場的關鍵市場洞察

供需的動態交互作用正在改變腸溶膠囊市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 世界人口中胃腸道疾病和病症的盛行率不斷增加
    • 在製藥業擴大腸溶膠囊的採用，以實現標靶給藥並提高療效
    • 越來越多的消費者喜歡口服藥物而不是其他給藥方式
  • 市場限制因素
    • 高品質明膠和其他原料的供應有限，破壞了供應鏈的一致性。
  • 市場機會
    • 利用腸溶膠囊提高針對腸道健康和保健的食品應用中的生物有效性度
    • 膠囊製造流程的技術進步提高了產品品質和性能
    • 擴大腸溶膠囊在動物用藥品的使用，以最佳化獸醫胃腸道治療藥物的輸送
  • 市場挑戰
    • 新配方複雜而漫長的核准流程減緩了新產品的上市速度

波特五力：駕馭腸溶膠囊市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解腸溶膠囊市場的外部影響

外部宏觀環境因素對腸溶膠囊市場表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解腸溶膠囊市場競爭格局

腸溶膠囊市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣腸溶膠囊市場供應商的績效評估

FPNV定位矩陣是評估腸溶膠囊市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了腸溶膠囊市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，腸溶膠囊市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界人口中胃腸道疾病和病症的盛行率不斷增加
      • 腸溶膠囊擴大被製藥業採用，用於標靶給藥和提高療效
      • 與其他給藥方式相比，越來越多的消費者更喜歡口服給藥
    • 抑制因素
      • 優質明膠和其他原料的供應有限，影響了供應鏈的一致性
    • 機會
      • 利用腸溶膠囊提高針對腸道健康和保健的營養保健品食品中的生物有效性度
      • 膠囊製造流程的技術進步可提高產品品質和性能
      • 擴大腸溶膠囊在獸藥中的使用，以最佳化動物胃腸道治療的給藥
    • 任務
      • 新配方複雜而漫長的核准流程延遲了新產品的上市時間
  • 市場區隔分析
    • 聚合物類型：合成聚合物因其優異的 pH 依賴性溶解度而被廣泛使用。
    • 用途：優先選用腸溶膠囊，以增強藥效。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章腸溶膠囊市場：功能性別

  • 延遲釋放膠囊
  • 速效膠囊
  • 緩釋性膠囊

第7章腸溶膠囊市場：依聚合物分類

  • 動物起源
    • 明膠
    • 蟲膠
  • 植物來源
    • 鄰苯二甲酸醋酸纖維素 (CAP)
    • 羥丙基甲基纖維素（HPMC）
  • 合成來源
    • 聚(甲基丙烯酸-甲基丙烯酸甲酯)
    • 聚醋酸乙烯酯鄰苯二甲酸酯 (PVAP)

第8章腸溶膠囊市場：按機制

  • 延遲釋放膠囊
  • 緩釋性膠囊
  • 速效膠囊

第9章腸溶膠囊市場：依通路分類

  • 醫院藥房
  • 網路商店
  • 零售藥房

第10章腸溶膠囊市場：依途徑

  • 口服
  • 直腸

第11章腸溶膠囊市場：依治療領域

  • 心臟病學
  • 糖尿病
  • 胃腸病學
  • 感染疾病
  • 神經病學
  • 腫瘤學

第12章美洲腸溶膠囊市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第13章亞太腸溶膠囊市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第14章歐洲、中東和非洲腸溶膠囊市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 贏創推出功能性口服膠囊「EUDRACAP」用於臨床前測試
  • 戰略分析和建議

公司名單

  • 1. ACG Worldwide
  • 2. Aenova Group
  • 3. Associated Biotech Group
  • 4. Biocaps Enterprises
  • 5. Bright Pharma Caps Inc.
  • 6. Captek Softgel International Inc.
  • 7. Chemcaps Limited
  • 8. Coating Place Inc.
  • 9. Farmacapsulas SA
  • 10. FUJI Capsule Co., Ltd.
  • 11. GELITA AG
  • 12. GMP Laboratories of America Inc.
  • 13. Hunan ER-Kang Pharmaceutical Co., Ltd.
  • 14. Lonza Group AG
  • 15. Mitsubishi Chemical Holdings Corporation
  • 16. Natural Capsules Limited
  • 17. Nectar Lifesciences Ltd.
  • 18. NextPharma Technologies
  • 19. Qualicaps by Roquette
  • 20. Roxlor LLC
  • 21. Thermo Fisher Scientific Inc.
Product Code: MRR-3204321AF70B

The Enteric Capsule Market was valued at USD 674.53 million in 2023, expected to reach USD 713.32 million in 2024, and is projected to grow at a CAGR of 5.81%, to USD 1,001.63 million by 2030.

The enteric capsule market encompasses products designed for targeted drug delivery, ensuring that active pharmaceutical ingredients (APIs) are released in the intestine rather than the stomach. These capsules are crucial for protecting sensitive APIs from stomach acid, enhancing drug efficacy, and reducing gastrointestinal side effects. They are widely applied in pharmaceuticals for medications like antibiotics, enzymes, and probiotic formulations. The end-use scope extends to pharmaceuticals and dietary supplements, with key sectors being hospitals, clinics, and online pharmacies. The market is driven by the escalating demand for targeted drug delivery systems, an aging population necessitating improved drug administration methods, and increased awareness of gastrointestinal health. Technological advancements in capsule design and materials present multiple growth opportunities, particularly in developing biodegradable and non-toxic coatings. An emerging opportunity lies in personalized medicine, where enteric capsules can be tailored for specific patient needs, thus opening avenues for precision drug delivery. A challenge that manufacturers face is the high cost of raw materials and stringent regulatory requirements, which can hinder market growth. Additionally, the need for specialized infrastructure to manufacture these capsules also poses a limitation. To overcome these challenges, businesses can invest in research and development to innovate cost-effective manufacturing processes and explore biodegradable materials for capsule production. The most promising areas of innovation include the development of multi-compartment capsules, which can house different APIs released sequentially for complex therapeutic regimens. Further exploration into nanotechnology for enhanced stability of enteric capsules in variable pH conditions could also offer a competitive edge. The market is moderately competitive, with key players focusing on mergers, acquisitions, and strategic partnerships to expand market presence and enhance product offerings. Stakeholders in the enteric capsule market must emphasize product differentiation and compliance with stringent health regulations to sustain growth amid evolving consumer demands.

KEY MARKET STATISTICS
Base Year [2023] USD 674.53 million
Estimated Year [2024] USD 713.32 million
Forecast Year [2030] USD 1,001.63 million
CAGR (%) 5.81%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Enteric Capsule Market

The Enteric Capsule Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of gastrointestinal diseases and disorders among global population
    • Growing adoption of enteric capsules in pharmaceutical industry for targeted drug delivery and improved efficacy
    • Rising consumer preference for oral drug administration over other delivery methods
  • Market Restraints
    • Limited availability of high-quality gelatin and other raw materials disrupt supply chain consistency
  • Market Opportunities
    • Leveraging enteric capsules for improved bioavailability in nutraceutical applications targeting gut health and wellness
    • Technological advancements in capsule manufacturing processes to enhance product quality and performance
    • Expanding the use of enteric-coated capsules in veterinary medicine to optimize the delivery of gastrointestinal treatments for animals
  • Market Challenges
    • Intricate and time-consuming approval processes for new formulations delay time-to-market for new products

Porter's Five Forces: A Strategic Tool for Navigating the Enteric Capsule Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Enteric Capsule Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Enteric Capsule Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Enteric Capsule Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Enteric Capsule Market

A detailed market share analysis in the Enteric Capsule Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Enteric Capsule Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Enteric Capsule Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Enteric Capsule Market

A strategic analysis of the Enteric Capsule Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Enteric Capsule Market, highlighting leading vendors and their innovative profiles. These include ACG Worldwide, Aenova Group, Associated Biotech Group, Biocaps Enterprises, Bright Pharma Caps Inc., Captek Softgel International Inc., Chemcaps Limited, Coating Place Inc., Farmacapsulas S.A, FUJI Capsule Co., Ltd., GELITA AG, GMP Laboratories of America Inc., Hunan ER-Kang Pharmaceutical Co., Ltd., Lonza Group AG, Mitsubishi Chemical Holdings Corporation, Natural Capsules Limited, Nectar Lifesciences Ltd., NextPharma Technologies, Qualicaps by Roquette, Roxlor LLC, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Enteric Capsule Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Functionality, market is studied across Delayed-Release Capsules, Immediate-Release Capsules, and Sustained-Release Capsules.
  • Based on Polymer, market is studied across Animal Origin, Plant-based, and Synthetic Origin. The Animal Origin is further studied across Gelatin and Shellac. The Plant-based is further studied across Cellulose Acetate Phthalate (CAP) and Hydroxypropyl Methylcellulose (HPMC). The Synthetic Origin is further studied across Poly(methacrylic acid-co-methyl methacrylate) and Polyvinyl Acetate Phthalate (PVAP).
  • Based on Mechanism, market is studied across Delayed-Release Capsules, Extended-Release Capsules, and Immediate-Release Capsules.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Stores, and Retail Pharmacies.
  • Based on Route of Administration, market is studied across Oral and Rectal.
  • Based on Therapeutic Area, market is studied across Cardiology, Diabetes, Gastroenterology, Infectious Diseases, Neurology, and Oncology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of gastrointestinal diseases and disorders among global population
      • 5.1.1.2. Growing adoption of enteric capsules in pharmaceutical industry for targeted drug delivery and improved efficacy
      • 5.1.1.3. Rising consumer preference for oral drug administration over other delivery methods
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of high-quality gelatin and other raw materials disrupt supply chain consistency
    • 5.1.3. Opportunities
      • 5.1.3.1. Leveraging enteric capsules for improved bioavailability in nutraceutical applications targeting gut health and wellness
      • 5.1.3.2. Technological advancements in capsule manufacturing processes to enhance product quality and performance
      • 5.1.3.3. Expanding the use of enteric-coated capsules in veterinary medicine to optimize the delivery of gastrointestinal treatments for animals
    • 5.1.4. Challenges
      • 5.1.4.1. Intricate and time-consuming approval processes for new formulations delay time-to-market for new products
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Polymer Type: Wide use of synthetic polymers owing to their excellent pH-dependent solubility
    • 5.2.2. Applications: Preference for enteric capsules due to their enhancing drug efficacy
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Enteric Capsule Market, by Functionality

  • 6.1. Introduction
  • 6.2. Delayed-Release Capsules
  • 6.3. Immediate-Release Capsules
  • 6.4. Sustained-Release Capsules

7. Enteric Capsule Market, by Polymer

  • 7.1. Introduction
  • 7.2. Animal Origin
    • 7.2.1. Gelatin
    • 7.2.2. Shellac
  • 7.3. Plant-based
    • 7.3.1. Cellulose Acetate Phthalate (CAP)
    • 7.3.2. Hydroxypropyl Methylcellulose (HPMC)
  • 7.4. Synthetic Origin
    • 7.4.1. Poly(methacrylic acid-co-methyl methacrylate)
    • 7.4.2. Polyvinyl Acetate Phthalate (PVAP)

8. Enteric Capsule Market, by Mechanism

  • 8.1. Introduction
  • 8.2. Delayed-Release Capsules
  • 8.3. Extended-Release Capsules
  • 8.4. Immediate-Release Capsules

9. Enteric Capsule Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospital Pharmacies
  • 9.3. Online Stores
  • 9.4. Retail Pharmacies

10. Enteric Capsule Market, by Route of Administration

  • 10.1. Introduction
  • 10.2. Oral
  • 10.3. Rectal

11. Enteric Capsule Market, by Therapeutic Area

  • 11.1. Introduction
  • 11.2. Cardiology
  • 11.3. Diabetes
  • 11.4. Gastroenterology
  • 11.5. Infectious Diseases
  • 11.6. Neurology
  • 11.7. Oncology

12. Americas Enteric Capsule Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Enteric Capsule Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Enteric Capsule Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Evonik launches EUDRACAP preclinic functional oral capsule for preclinical trials
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ACG Worldwide
  • 2. Aenova Group
  • 3. Associated Biotech Group
  • 4. Biocaps Enterprises
  • 5. Bright Pharma Caps Inc.
  • 6. Captek Softgel International Inc.
  • 7. Chemcaps Limited
  • 8. Coating Place Inc.
  • 9. Farmacapsulas S.A
  • 10. FUJI Capsule Co., Ltd.
  • 11. GELITA AG
  • 12. GMP Laboratories of America Inc.
  • 13. Hunan ER-Kang Pharmaceutical Co., Ltd.
  • 14. Lonza Group AG
  • 15. Mitsubishi Chemical Holdings Corporation
  • 16. Natural Capsules Limited
  • 17. Nectar Lifesciences Ltd.
  • 18. NextPharma Technologies
  • 19. Qualicaps by Roquette
  • 20. Roxlor LLC
  • 21. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. ENTERIC CAPSULE MARKET RESEARCH PROCESS
  • FIGURE 2. ENTERIC CAPSULE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ENTERIC CAPSULE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. ENTERIC CAPSULE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. ENTERIC CAPSULE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ENTERIC CAPSULE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ENTERIC CAPSULE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ENTERIC CAPSULE MARKET DYNAMICS
  • TABLE 7. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY DELAYED-RELEASE CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY IMMEDIATE-RELEASE CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY SUSTAINED-RELEASE CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY GELATIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY SHELLAC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY CELLULOSE ACETATE PHTHALATE (CAP), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE (HPMC), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY POLY(METHACRYLIC ACID-CO-METHYL METHACRYLATE), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY POLYVINYL ACETATE PHTHALATE (PVAP), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY DELAYED-RELEASE CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY EXTENDED-RELEASE CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY IMMEDIATE-RELEASE CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY RECTAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL ENTERIC CAPSULE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES ENTERIC CAPSULE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 172. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 181. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 189. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 190. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 198. THAILAND ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 199. THAILAND ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 207. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 208. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA ENTERIC CAPSULE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 226. DENMARK ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 227. DENMARK ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 235. EGYPT ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 236. EGYPT ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 243. EGYPT ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 244. FINLAND ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 245. FINLAND ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 253. FRANCE ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 254. FRANCE ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 262. GERMANY ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 263. GERMANY ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 264. GERMANY ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 265. GERMANY ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 271. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 272. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 273. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 274. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 275. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 276. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 277. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 278. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 279. ISRAEL ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 280. ITALY ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 281. ITALY ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 282. ITALY ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 283. ITALY ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 284. ITALY ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 285. ITALY ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 286. ITALY ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 287. ITALY ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 288. ITALY ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 289. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 290. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 291. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 292. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 293. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 294. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 295. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 296. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 297. NETHERLANDS ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 298. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 299. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 300. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 301. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 302. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 303. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 304. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 305. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 306. NIGERIA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 307. NORWAY ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 308. NORWAY ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 309. NORWAY ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 310. NORWAY ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 311. NORWAY ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 312. NORWAY ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 313. NORWAY ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 314. NORWAY ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 315. NORWAY ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 316. POLAND ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 317. POLAND ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 318. POLAND ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 319. POLAND ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 320. POLAND ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 321. POLAND ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 322. POLAND ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 323. POLAND ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 324. POLAND ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 325. QATAR ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 326. QATAR ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 327. QATAR ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 328. QATAR ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 329. QATAR ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 330. QATAR ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 331. QATAR ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 332. QATAR ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 333. QATAR ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 334. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 335. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 336. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 337. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 338. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 339. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 340. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 341. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 342. RUSSIA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 343. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 344. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 345. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 346. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY PLANT-BASED, 2018-2030 (USD MILLION)
  • TABLE 347. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY SYNTHETIC ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 348. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 349. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 350. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 351. SAUDI ARABIA ENTERIC CAPSULE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 352. SOUTH AFRICA ENTERIC CAPSULE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 353. SOUTH AFRICA ENTERIC CAPSULE MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 354. SOUTH AFRICA ENTERIC CAPSULE MARKET SIZE, BY ANIMAL ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 355. S